首页> 外文期刊>Tumour biology : >Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach
【24h】

Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach

机译:应用iTRAQ耦合ESI-MS / MS方法对视网膜母细胞瘤患者玻璃体液中差异表达蛋白质进行蛋白质组学分析

获取原文
获取原文并翻译 | 示例
       

摘要

There is close proximity of vitreous humor with the tumor bulk in eyes with retinoblastoma. This renders vitreous humor a promising source to evaluate disease-specific protein targets in retinoblastoma. We studied the differential proteome of vitreous fluid in retinoblastoma tumors (n = 4) as compared to controls (n = 4). The vitreous humor was depleted off the high abundant fraction using MARS-6 affinity column. Subsequently, the tryptic peptides were derivatised with iTRAQ labels. The labelled peptides were pooled and subjected to fractionation using bRPLC. This was followed by protein identification and quantification using electrospray ionisation mass spectrometry (ESI-MS/MS) approach. The identified proteins were subjected to bioinformatics analysis utilizing PANTHER 7.0 and IPA software. Four hundred and thirty-one non-redundant (362 upregulated and 69 downregulated) proteins (aeyen2 unique peptides, +/- 1.5 folds, p < 0.05) were identified. The majority of the proteins were cytoplasmic (40 %), majorly involved in catalytic (32.7 %) and binding activities (26.3 %). Highly deregulated proteins included MMP2, TNC, CD44, SUZ12 and CRABP1. The protein expression of GFAP, CRABP1, MMP2 and TNC was validated by western blotting. Pathway and network analyses revealed p38MAPK and Akt signalling to be the most significantly regulated pathways in retinoblastoma. This is the first report of differential vitreous proteome of retinoblastoma and highlights novel protein targets, such as MMP2, TNC and CRABP1. Further investigations into unravelling the biological role of the proteins and their prospects of being utilised as potential candidates in therapeutics are warranted.
机译:玻璃体液与视网膜母细胞瘤的眼睛中的肿瘤块非常接近。这使得玻璃体液成为评估视网膜母细胞瘤中疾病特异性蛋白质靶标的有希望的来源。我们研究了视网膜母细胞瘤肿瘤(n = 4)与对照组(n = 4)相比的玻璃体液差异蛋白质组。使用MARS-6亲和柱将玻璃体液从高丰度部分中清除。随后,胰蛋白酶消化的肽用iTRAQ标记衍生。合并标记的肽,并使用bRPLC进行分离。随后使用电喷雾电离质谱(ESI-MS / MS)方法进行蛋白质鉴定和定量。使用PANTHER 7.0和IPA软件对鉴定出的蛋白质进行生物信息学分析。鉴定了413个非冗余蛋白(362个上调和69个下调)(aeyen2独特肽,+ /-1.5倍,p <0.05)。大多数蛋白质是细胞质的(40%),主要参与催化(32.7%)和结合活性(26.3%)。高度失调的蛋白质包括MMP2,TNC,CD44,SUZ12和CRABP1。通过western blotting验证了GFAP,CRABP1,MMP2和TNC的蛋白表达。途径和网络分析表明,p38MAPK和Akt信号传导是视网膜母细胞瘤中最明显调控的途径。这是视网膜母细胞瘤玻璃体差异蛋白质组的首次报道,并着重介绍了新型蛋白质靶标,例如MMP2,TNC和CRABP1。必须进一步研究以阐明蛋白质的生物学作用及其在治疗中可能用作候选药物的前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号